Swiss industrial and technology sector economic outlook

The Swiss technology and medical technology sectors are facing economic challenges characterized by uneven growth and declining competitiveness. In the broader technology industry, data from Swissmem indicated a fragile recovery in the first half of 2026, with rising order intakes and turnover driven primarily by large companies while small and medium-sized enterprises experienced a turnover decline of 3.8%.

By late 2026, specific concerns intensified within the medical technology sector. Although the industry has historically grown faster than the overall Swiss economy—with an average revenue growth of 5.5% in 2024 and 2025—current growth rates have fallen below the ten-year average of 6.4%. Despite contributing approximately 10% to Switzerland's industrial value added and 5.5 billion francs to the trade surplus, the sector is experiencing a divergence between revenue growth and investment attractiveness.

Industry association Swiss Medtech reported that 53% of surveyed companies view Swiss competitiveness as worse than five years ago, and 43% of companies plan no new investments, marking a record low. Employment growth has also slowed significantly, with recent net new job creation of approximately 200, compared to a ten-year average of 1,500 per year.

To combat these trends, Swiss Medtech is calling on policymakers to reduce administrative burdens and eliminate superfluous formalities. Additional pressures include the potential migration of innovation, as foreign investment increasingly prioritizes access to new technology know-how over traditional expertise. Broader economic risks cited include geopolitical tensions, rising US tariffs, and maritime route disruptions.